Indianapolis Biotech Marks Growing Milestone in the Fight Against Blood CancerINDIANAPOLIS--(BUSINESS WIRE)--This week, Ossium Health hosted a facility tour and reception at its Indianapolis ...
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...
Rich Market with Strategically Aligned CustomersROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” ...
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with the American Heart Association, the world’s leading nonprofit organization focused on heart and brain ...
"A federal pilot built on the 0.3% THC loophole is reshaping cannabinoid access policy-without FDA approval, without ...
Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC / ACCESS Newswire / April 9, 2026 / Queue Ventures Ltd. ("Queue" or the "Company") is ...
BFA Law is investigating ADMA Biologics after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws.NEW YORK--(BUSINESS WIRE)--$ADMA ...
Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...
Neuro-symbolic, multi-agent AI system achieves 4x faster trial matching with oncologist-confirmed accuracy across 17,000+ ...
NR is the first among NR, NMN, and NAD+ to receive a pharmacopeial quality benchmark, reinforcing Niagen Bioscience’s leadership in NAD+ science and ingredient qualityLOS ANGELES--(BUSINESS ...
Eight studies demonstrate how clinically relevant models and integrated data can reduce translational risk and guide development decisions HACKENSACK, NJ / ACCESS Newswire / April 9, 2026 / Champions ...
Preliminary Q1 2026 net product revenue of approximately $44.2 million, representing an ~168% year-over-year increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results